Controversies in Cardiology

This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines th...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Ambrose, John A. (Επιμελητής έκδοσης), Rodríguez, Alfredo E. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Έκδοση:1st ed. 2015.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Section 1.  Special situations of controversial, increased, or unknown cardiovascular risk
  • Optimal management of old and new CV risk factors
  • Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive?
  • Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients?
  • Treatment of diabetes and coronary artery disease
  • Elevated triglycerides and atherosclerosis
  • Patent foramen ovale and stroke
  • Systolic hypertension in the elderly
  • Section 2. Cardiovascular diagnosis
  • CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease
  • Takotsubo cardiomyopathy- frequency, diagnosis and management
  • Chest pain in women – evaluation and management
  • Section 3. Cardiovascular management
  • Myocardial infarction and “normal” coronary arteries on angiography
  • Management of intractable angina when PCI or CABG is not an option
  • Invasive management of CAD in patients on anticoagulants
  • Managing intracoronary thrombus during PCI
  • Optimal management of multivessel disease – PCI vs CABG vs medical therapy alone
  • Appropriate therapy for severe left main disease
  • Radial vs femoral procedures for angiography and PCI
  • DAPT after stenting in stable and acute coronary syndromes – does the drug combination really matter?
  • CAD management in patients with significant renal dysfunction or on dialysis
  • What is the optimal stent design?
  • Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and   cilostazol
  • When should ablation be considered in the treatment of atrial fibrillation?
  • Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access?
  • Cost benefits of TAVR- Should the indications be expanded?.